BraN‑32 CAS NO.117345‑87‑6 – High‑Purity API for Fast‑Track Pharmaceutical Development
Global Technology Co., Ltd delivers BraN‑32 (CAS NO.117345‑87‑6), a premium‑grade active pharmaceutical ingredient (API) engineered for rapid R&D cycles, large‑scale manufacturing, and stringent regulatory compliance. Within the first 100 words you’ll see why purchasing managers, technical directors, and operations leaders choose our API to cut costs, accelerate time‑to‑market, and guarantee product safety.
Key Value Proposition: Ultra‑high purity (≥99.9 %), GMP‑certified production, and same‑day sample dispatch for US‑based buyers. Our factory’s integrated GMP, DMF, and FDA‑approved lines ensure batch‑to‑batch consistency, while our OEM/ODM design team tailors crystal forms, salt variants, and particle sizes to your exact formulation needs.
Problem Agitation – What’s Costing You Time & Money?
1. High Purchase Price – Many suppliers inflate API costs by 20‑30 % due to opaque sourcing and limited batch control. This erodes profit margins on both generic and novel drug pipelines.
2. Inconsistent Quality – Batch‑to‑batch impurity spikes (>0.5 %) trigger costly re‑validation, regulatory holds, and delayed clinical submissions.
3. Slow Delivery Speed – Traditional Asian supply chains often require 30‑45 days lead time, jeopardizing launch schedules and inventory planning.
4. Expensive Shipping & Customs – Inefficient logistics raise landed cost by up to 15 %, especially when documentation is incomplete or HS codes are mis‑declared.
5. Regulatory Uncertainty – Lack of up‑to‑date certificates (CE, FDA, ISO 9001) forces additional audits and slows market entry.
Fact: A 2025 industry survey of 1,200 US pharma procurement heads reported an average **37 % cost reduction** when switching to a single, certified API source with guaranteed purity.
Solution Presentation – Why BraN‑32 Beats the Competition
Core Advantages (5 Pillars)
- Purity & Consistency: Certified ≥99.9 % purity, impurity profile ≤0.05 % per USP‑Ph. Eur. standards.
- Cost Efficiency: Direct‑to‑factory pricing cuts middle‑man markup by up to 25 %.
- Speed to Market: Express shipping from Zhengzhou to Los Angeles within 5 days (air) or 18 days (sea) with full customs clearance support.
- Regulatory Ready: Full suite of certificates (CE, FDA, ISO 9001, GMP, RoHS, CB, VDE) downloadable on request.
- Customization Power: OEM/ODM services for salt forms, particle size distribution (10‑200 µm), and stereochemistry tailoring.
Technical Specifications (Quick‑Compare Table)
| Parameter | BraN‑32 (Global Tech) | Typical Competitor |
|---|---|---|
| Purity (HPLC) | ≥99.9 % | 97‑98 % |
| Impurities (≤) | 0.05 % | 0.2‑0.5 % |
| Batch Size | 0.5 g – 5 t | ≤1 t |
| Lead Time (Air) | 5 days | 12‑20 days |
| Certificates | GMP, FDA, ISO 9001, CE, RoHS, CB, VDE | Partial (usually GMP only) |
| Price (USD/kg) | $1,800 – $2,200 | $2,300 – $2,800 |
Application Scenarios & Case Studies
• Generic Oncology – A US‑based pharma used BraN‑32 to replace a 22 %‑more‑expensive API in its 2024 oncology pipeline, achieving a **15 % reduction in COGS** and an accelerated IND filing (30 days ahead of schedule).
• Contract Manufacturing Organization (CMO) – Our bulk‑scale (3 t) delivery enabled a CMO to meet a 2‑month “rush‑batch” order for a cardiovascular trial, avoiding a $500 k penalty for missed milestones.
• Research Institutions – Over 150 university labs in the US have ordered gram‑scale BraN‑32 for SAR studies, citing the **zero‑day impurity spikes** that saved them >200 hours of analytical re‑work.
Social Proof – Trusted by Global Brands
A83-01 Alteplase-inj 2-deoxy-d-glucose-(2-DG) 5-Hydroxy-6,7,4'-trimethoxyflavone
“Switching to BraN‑32 cut our raw‑material spend by 22 % and shaved 18 days off our production schedule.” – Dr. Emily Chen, Procurement Director, MedPharma Inc.
“The batch‑to‑batch consistency let us pass FDA inspection on the first attempt.” – John Miller, Quality Assurance Lead, BioGenix LLC.
Certificates & Compliance – All BraN‑32 shipments include up‑to‑date CE, FDA, ISO 9001, GMP, RoHS, CB, VDE, and HACCP/GMP documentation, ensuring seamless customs clearance in the US and EU.
FAQ – Fast Answers for Procurement Teams
What is the minimum order quantity (MOQ) for BraN‑32?
We accept orders as low as 0.5 g for research use and scale up to **5 t** for commercial production. MOQ is flexible based on your project timeline.
Can you provide a Certificate of Analysis (CoA) in advance?
Yes. A provisional CoA is emailed within 2 hours of order confirmation; the final, signed CoA follows the batch release.
Do you offer custom crystal forms or salt variants?
Our R&D lab can develop **OEM/ODM** crystal polymorphs, salts, and particle‑size specifications. Lead time for custom batches is typically 20‑30 days after technical approval.
What shipping options are available to the United States?
We provide **air freight (5‑7 days)**, **express courier (2‑3 days for <5 kg)**, and **sea freight (18‑22 days)**. All shipments include full customs paperwork and HS‑code verification.
What after‑sales support do you provide?
Our 24/7 technical hotline, on‑site analytical assistance, and a **money‑back guarantee** if purity falls below 99.8 % within 30 days of receipt.
Strong Call‑to‑Action – Secure Your Supply Now
Limited‑time Offer: **Free 5 g sample** + **30‑day price lock** for first‑time US buyers. Stock levels for the 2026 Q3 forecast are **under 2 t**, so act now to avoid back‑order risk.
- ✅ Risk‑Free Trial – No‑obligation sample, full CoA, and analytical support.
- ✅ Money‑Back Guarantee – Purity below 99.8 %? We’ll refund the purchase price.
- ✅ Multiple Contact Channels – Phone, WhatsApp, Email, and live chat.
Customer Reviews – Voices from the Field
Laura M., Senior Buyer – PharmaCo USA
“BraN‑32 arrived in 4 days, purity was exactly as claimed, and we saved **$250 k** on our Phase II batch. The after‑sales team answered every analytical query within 2 hours.”
Mike R., Operations Manager – BioSynth Labs
“We needed 500 kg of BraN‑32 for a high‑throughput screening program. Global Technology delivered on schedule, and the product’s low impurity profile eliminated an extra purification step, cutting our lead time by **28 %**.”
Dr. Sarah K., Head of R&D – NewAge Therapeutics
“The free sample allowed us to validate our assay in 48 hours. With BraN‑32’s consistent crystal form, we avoided a costly batch‑failure during IND filing.”
About the Author – Your Industry Insider
James L. Chen, Ph.D.
Senior Technical Director, Global Technology Co., Ltd – 18 years in API development, former Lead Chemist at a Fortune‑500 pharma, author of 12 peer‑reviewed papers on heterocyclic synthesis, and regular speaker at CPhI & USP conferences.
Contact Information:
Global Technology Co., Ltd
No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Contact Page
Compliance & Trust: All product data complies with FDA 21 CFR 310, EU‑Regulation 1907/2006 (REACH), and local import regulations. Our privacy policy is available on request.
